Streetbeat News

Products Services

AKAN

Akanda Corp. (NASDAQ:AKAN) shares rose after announcing plans to explore Bitcoin, blockchain, and AI applications in the cannabis industry, aiming to address banking issues and enhance product traceability and research. The company also closed a $5 million public offering, with intentions to reduce debt and expand, particularly through its UK business and technology segments.

Portfolio Pulse from Erica Kollmann

March 28, 2024 | 5:02 pm

EVLV

NY Mayor Eric Adams announced the deployment of electromagnetic weapon detection systems in New York subway stations to enhance security. EVLV, a company involved in security technologies, may see an impact.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 4:58 pm

WNNR

Andretti Acquisition Corp (NYSE:WNNR) shares surged after completing a business combination with Zapata Computing, which will now operate as Zapata AI and be listed on Nasdaq under the ticker ZPTA. The merger aims to fuel growth and innovation in industrial generative AI.

Portfolio Pulse from Adam Eckert

March 28, 2024 | 4:58 pm

CVS

ELV

NVO

A study reveals Novo Nordisk's diabetes drug Ozempic could be produced for under $5, contrasting its $1,000 U.S. price tag. The study, involving Yale University and others, highlights the affordability issue in diabetes care. Major insurers like CVS Health and Elevance Health announced coverage for another Novo Nordisk drug, Wegovy, for certain Medicare patients. Novo Nordisk defends its pricing, citing significant R&D investments and efforts to ensure patient access through rebates and discounts.

Portfolio Pulse from Vandana Singh

March 28, 2024 | 4:54 pm

BDRX

Biodexa Pharmaceuticals (NASDAQ:BDRX) reports promising early trial results for its investigational drug MTX110, aimed at treating Diffuse Midline Glioma (DMG) in children and Recurrent Glioblastoma (rGBM) in adults. The drug, leveraging a novel delivery method and Convection Enhanced Delivery (CED) technology, has shown potential in significantly extending survival rates in patients beyond historical figures. The company's phase 1 trials have demonstrated encouraging outcomes, with median overall survival rates surpassing previous benchmarks. BDRX shares surged 66.5% to $1.43.

Portfolio Pulse from Vandana Singh

March 28, 2024 | 4:43 pm

F

Ford is reducing its workforce at the Rogue Electric Vehicle Center by two-thirds due to decreased demand for the F-150 Lightning, shifting focus to smaller, cheaper EVs. The company plans to reallocate 1,400 workers, with no anticipated job losses, and add a third shift at the Michigan Assembly Plant to accommodate the production of other models. This move contrasts sharply with the previous year's hiring spree to meet the high demand for the F-150 Lightning.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 4:25 pm

NKLA

Nikola Corporation (NASDAQ:NKLA) shares have surged over 50% in the past five days, following the unveiling of its first commercial hydrogen fueling station in Alberta, Canada, and the inauguration of a HYLA hydrogen refueling station in Southern California. The stock has become a trending ticker on WallStreetBets, with 17.78% of shares sold short, contributing to significant price movements. Analysts use various methods for stock prediction, including technical analysis, with Nikola's 200-day moving average at $1.17, above its current price.

Portfolio Pulse from Erica Kollmann

March 28, 2024 | 4:11 pm

ISUZY

TM

Toyota Motor Corporation (NYSE:TM) reported a 6.9% drop in global sales for February, marking its first year-over-year decrease in thirteen months. The decline was attributed to a production slump of 2.6% and intense competition, particularly in China where a price battle is ongoing. Despite a 16% surge in U.S. sales and a 14% increase in Europe, sales in Japan plummeted due to production halts at Daihatsu. Toyota also announced plans to start mass production of an electric Hilux pickup by the end of 2025, following Isuzu Motors, Ltd. (OTC:ISUZY) in the electric pickup market in Thailand.

Portfolio Pulse from Nabaparna Bhattacharya

March 28, 2024 | 4:11 pm

ALBT

Avalon GloboCare shares surged following the announcement of the extension of its exclusive distribution agreement with Qi Diagnostics for the KetoAir Breathalyzer Device and related accessories in North America, South America, the UK, and the EU.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 4:05 pm

CVSI

CV Sciences, Inc. (OTCQB:CVSI) reported its fiscal year 2023 financial results, showing a gross margin increase to 44.3% from 34.2% in 2022, and a net income of $3.1 million, reversing a $9.1 million net loss from the previous year. Revenue remained flat at $16 million, while gross profit rose to $7 million from $5.5 million. Operating expenses decreased significantly to $3.7 million from $12.4 million. The company highlighted its focus on innovation and market share growth in the CBD sector, particularly through new product development like pet chews.

Portfolio Pulse from Jelena Martinovic

March 28, 2024 | 4:04 pm